These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 9652425

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM, Voltersvik P, Røsok BI, Olofsson J, Asjö B.
    AIDS Res Hum Retroviruses; 2000 Feb 10; 16(3):191-201. PubMed ID: 10710207
    [Abstract] [Full Text] [Related]

  • 5. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
    Landay AL, Bettendorf D, Chan E, Spritzler J, Schmitz JL, Bucy RP, Gonzalez CJ, Schnizlein-Bick CT, Evans T, Squires KE, Phair JP.
    AIDS Res Hum Retroviruses; 2002 Jan 20; 18(2):95-102. PubMed ID: 11839142
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
    Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A.
    AIDS; 2000 May 05; 14(7):761-70. PubMed ID: 10839583
    [Abstract] [Full Text] [Related]

  • 8. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.
    Notermans DW, Jurriaans S, de Wolf F, Foudraine NA, de Jong JJ, Cavert W, Schuwirth CM, Kauffmann RH, Meenhorst PL, McDade H, Goodwin C, Leonard JM, Goudsmit J, Danner SA.
    AIDS; 1998 Jan 22; 12(2):167-73. PubMed ID: 9468365
    [Abstract] [Full Text] [Related]

  • 9. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease.
    Mezzaroma I, Carlesimo M, Pinter E, Alario C, Sacco G, Muratori DS, Bernardi ML, Paganelli R, Aiuti F.
    AIDS; 1999 Jul 09; 13(10):1187-93. PubMed ID: 10416521
    [Abstract] [Full Text] [Related]

  • 10. CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.
    Carr A, Emery S, Kelleher A, Law M, Cooper DA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec 01; 13(4):320-6. PubMed ID: 8948369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
    Kuritzkes DR, Sevin A, Young B, Bakhtiari M, Wu H, St Clair M, Connick E, Landay A, Spritzler J, Kessler H, Lederman MM.
    J Infect Dis; 2000 Feb 01; 181(2):491-7. PubMed ID: 10669331
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease.
    Samri A, Goodall R, Burton C, Imami N, Pantaleo G, Kelleher A, Poli G, Gotch F, Autran B.
    Antivir Ther; 2007 Feb 01; 12(4):553-8. PubMed ID: 17668564
    [Abstract] [Full Text] [Related]

  • 15. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ, Feinberg JE, Balfour HH, Deyton LR, Chodakewitz JA, Fischl MA.
    N Engl J Med; 1997 Sep 11; 337(11):725-33. PubMed ID: 9287227
    [Abstract] [Full Text] [Related]

  • 16. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection.
    Giorgi JV, Majchrowicz MA, Johnson TD, Hultin P, Matud J, Detels R.
    AIDS; 1998 Oct 01; 12(14):1833-44. PubMed ID: 9792384
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
    Notermans DW, Pakker NG, Hamann D, Foudraine NA, Kauffmann RH, Meenhorst PL, Goudsmit J, Roos MT, Schellekens PT, Miedema F, Danner SA.
    J Infect Dis; 1999 Oct 01; 180(4):1050-6. PubMed ID: 10479130
    [Abstract] [Full Text] [Related]

  • 19. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.
    Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Santos J, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S, GESIDA 7011 Study Group.
    Lancet Infect Dis; 2015 Jul 01; 15(7):775-84. PubMed ID: 26062881
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
    Michelet C, Bellissant E, Ruffault A, Arvieux C, Delfraissy JF, Raffi F, Bazin C, Renard I, Sébille V, Chauvin JP, Dohin E, Cartier F.
    Clin Pharmacol Ther; 1999 Jun 01; 65(6):661-71. PubMed ID: 10391672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.